These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 37606177)
1. Influence of intestinal microecology in the development of gout or hyperuricemia and the potential therapeutic targets. Dang K; Zhang N; Gao H; Wang G; Liang H; Xue M Int J Rheum Dis; 2023 Oct; 26(10):1911-1922. PubMed ID: 37606177 [TBL] [Abstract][Full Text] [Related]
2. The Role of the Intestine in the Development of Hyperuricemia. Yin H; Liu N; Chen J Front Immunol; 2022; 13():845684. PubMed ID: 35281005 [TBL] [Abstract][Full Text] [Related]
3. Phytochemicals in traditional Chinese medicine can treat gout by regulating intestinal flora through inactivating NLRP3 and inhibiting XOD activity. Liu ZQ; Sun X; Liu ZB; Zhang T; Zhang LL; Wu CJ J Pharm Pharmacol; 2022 Jul; 74(7):919-929. PubMed ID: 35640306 [TBL] [Abstract][Full Text] [Related]
4. Gut microbiota remodeling: A promising therapeutic strategy to confront hyperuricemia and gout. Wang Z; Li Y; Liao W; Huang J; Liu Y; Li Z; Tang J Front Cell Infect Microbiol; 2022; 12():935723. PubMed ID: 36034697 [TBL] [Abstract][Full Text] [Related]
5. [Gout]. Tausche AK Z Rheumatol; 2022 Jun; 81(5):400-412. PubMed ID: 35596003 [TBL] [Abstract][Full Text] [Related]
6. The chemistry, processing, and preclinical anti-hyperuricemia potential of tea: a comprehensive review. Chen Y; Luo L; Hu S; Gan R; Zeng L Crit Rev Food Sci Nutr; 2023; 63(24):7065-7090. PubMed ID: 35236179 [TBL] [Abstract][Full Text] [Related]
8. The Interaction Between Dietary Fructose and Gut Microbiota in Hyperuricemia and Gout. Fang XY; Qi LW; Chen HF; Gao P; Zhang Q; Leng RX; Fan YG; Li BZ; Pan HF; Ye DQ Front Nutr; 2022; 9():890730. PubMed ID: 35811965 [TBL] [Abstract][Full Text] [Related]
9. Overnutrition-induced gout: An immune response to NLRP3 inflammasome dysregulation by XOD activity increased in quail. Wu H; Wang Y; Ren Z; Li Y; Huang J; Lin Z; Zhang B Front Immunol; 2022; 13():1074867. PubMed ID: 36569836 [TBL] [Abstract][Full Text] [Related]
10. The interplay between diet, urate transporters and the risk for gout and hyperuricemia: current and future directions. Torralba KD; De Jesus E; Rachabattula S Int J Rheum Dis; 2012 Dec; 15(6):499-506. PubMed ID: 23253231 [TBL] [Abstract][Full Text] [Related]
12. [Gout and cardiovascular risk]. Němec P Vnitr Lek; 2014 Oct; 60(10):893-901. PubMed ID: 25382012 [TBL] [Abstract][Full Text] [Related]
13. Recent approaches to gout drug discovery: an update. Otani N; Ouchi M; Kudo H; Tsuruoka S; Hisatome I; Anzai N Expert Opin Drug Discov; 2020 Aug; 15(8):943-954. PubMed ID: 32329387 [TBL] [Abstract][Full Text] [Related]
14. Uric acid, hyperuricemia and vascular diseases. Jin M; Yang F; Yang I; Yin Y; Luo JJ; Wang H; Yang XF Front Biosci (Landmark Ed); 2012 Jan; 17(2):656-69. PubMed ID: 22201767 [TBL] [Abstract][Full Text] [Related]
15. Hereditary nephropathy associated with hyperuricemia and gout. Puig JG; Miranda ME; Mateos FA; Picazo ML; Jiménez ML; Calvin TS; Gil AA Arch Intern Med; 1993 Feb; 153(3):357-65. PubMed ID: 8427538 [TBL] [Abstract][Full Text] [Related]
16. Exploring the Multifaceted Nexus of Uric Acid and Health: A Review of Recent Studies on Diverse Diseases. Kuwabara M; Fukuuchi T; Aoki Y; Mizuta E; Ouchi M; Kurajoh M; Maruhashi T; Tanaka A; Morikawa N; Nishimiya K; Akashi N; Tanaka Y; Otani N; Morita M; Miyata H; Takada T; Tsutani H; Ogino K; Ichida K; Hisatome I; Abe K Biomolecules; 2023 Oct; 13(10):. PubMed ID: 37892201 [TBL] [Abstract][Full Text] [Related]
17. ABCG2 as a therapeutic target candidate for gout. Fujita K; Ichida K Expert Opin Ther Targets; 2018 Feb; 22(2):123-129. PubMed ID: 29264928 [TBL] [Abstract][Full Text] [Related]
18. Clinical aspects of monosodium urate monohydrate crystal deposition disease (gout). Becker MA Rheum Dis Clin North Am; 1988 Aug; 14(2):377-94. PubMed ID: 3051156 [TBL] [Abstract][Full Text] [Related]
19. Hyperuricemia, the kidneys, and the spectrum of associated diseases: a narrative review. Jalal DI Curr Med Res Opin; 2016 Nov; 32(11):1863-1869. PubMed ID: 27470664 [TBL] [Abstract][Full Text] [Related]